Skip to main content

Cosmos Health Inc.

COSM
Exchange
Nasdaq
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
SEC CIK
0001474167

In the last 90 days, Cosmos Health Inc. insiders filed 2 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $389.5K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Cosmos Health Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
1 insider, $210.0K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$210.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Cosmos Health Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Cosmos Health Inc.
NameTitleLast reported holdingLast filingFilings, past year
Siokas GrigoriosChief Executive Officer14,597,917Jul 31, 202621
Terzis GeorgiosChief Financial Officer2,563,805Jul 30, 20263
Karkantzos Theodoros ChristosDirector35,000Jun 11, 20261
Hoidas John JamesDirector50,000Jun 11, 20261
Demetriades Demetrios G.Secretary55,000Jun 11, 20261
Aslidis AnastasiosDirector100,000Jun 11, 20261
Bhutawala SuhelDirector65,000Jun 11, 20261
Ziegler ManfredDirector5,000Aug 4, 20230
Bardakis NikolaosChief Operating Officer10,000Aug 1, 20230
Ignatiades PavlosChief Communications Officer5,000Jul 28, 20230
Goldstein PeterDirector, 10% Owner157,100Jul 28, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 27, 2023 (view filing)Dec 19, 202239 daysSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, $.001 par value+260.9K$11.50+$3.00M+30.0%1.13M afterAmended
Dec 21, 2022 (view filing)Dec 192 daysSiokas GrigoriosChief Executive OfficerPPurchase+260.9K$11.50+$3.00M–260.9K afterFrom originalDerivative
Nov 29, 2022 (view filing)Nov 281 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, $.001 par value+801.3K$0.62+$496.8K+4.1%20.1M afterAmended
Oct 24, 2022 (view filing)12:56 PM ETOct 204 daysSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, $.001 par value+12.5M$0.12+$1.50M+182.9%19.3M after
Oct 24, 2022 (view filing)12:56 PM ETOct 204 daysSiokas GrigoriosChief Executive OfficerPPurchase+30.3M$0.12+$3.64M–12.5M afterDerivative3 lots
Aug 4, 2022 (view filing)Jun 1550 daysSiokas GrigoriosChief Executive OfficerPPurchase+5.07M$0.0613+$310.9K–5.07M afterAmendedDerivative2 lots
Dec 14, 2021 (view filing)Dec 86 daysLateSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001 per share+125.0K$6.00+$750.0K+1.9%6.83M after
Oct 22, 2021 (view filing)2:41 PM ETOct 22Same daySiokas GrigoriosChief Executive OfficerSSaleCommon Stock, par value $0.001 per share−341.9K$0.8235−$281.6K−4.8%6.71M after9 lots
Jul 28, 2021 (view filing)Jul 208 daysLateGoldstein PeterDirector, 10% OwnerPPurchaseCommon Stock, $.001 par value+100.0K$0.00$0+175.1%157.1K after
Jul 21, 2021 (view filing)3:14 PM ETJul 201 daySiokas GrigoriosChief Executive OfficerSSaleCommon Stock, par value $0.001 per share−273.4K$2.32−$634.8K−3.7%7.05M after8 lots
Jul 21, 2021 (view filing)Jul 192 daysSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $0.001 per share+208.3K$6.00+$1.25M+2.9%7.32M after
Jul 14, 2021 (view filing)Jul 131 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $0.001 per share+166.7K$6.00+$1.00M+2.4%7.12M after